IL36RN and psoriasis 14, pustular: We and others have shown that recessive mutations of the IL-36 receptor antagonist (IL36RN) are associated with generalized pustular psoriasis (GPP), a disease variant characterized by severe extracutaneous symptoms (Marrakchi et al., 2011, Onoufriadis et al., 2011).